36:@0.092505:0.957873:0.109687:0.957873:0.109687:0.938882:0.092505:0.938882:0.008591:0.008591
CHAPTER 2:@0.117647:0.067123:0.190298:0.067123:0.190298:0.047044:0.117647:0.047044:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.008197
2:@0.038824:0.247137:0.060302:0.247137:0.060302:0.199659:0.038824:0.199659:0.021478
mutated in the TP53 gene, are resistant. Dots represent the mean of technical duplicates. Error bars represent :@0.117647:0.118163:0.856208:0.118163:0.856208:0.101494:0.117647:0.101494:0.014138:0.009058:0.005360:0.007209:0.005080:0.007452:0.009320:0.002820:0.004594:0.009618:0.002820:0.005416:0.009245:0.007396:0.002820:0.010926:0.009955:0.008535:0.008535:0.002820:0.007900:0.007396:0.009488:0.007153:0.003679:0.002820:0.007433:0.006089:0.007396:0.002820:0.006089:0.007396:0.006219:0.004594:0.006145:0.005358:0.007435:0.009320:0.005267:0.003679:0.002820:0.013279:0.008853:0.005267:0.006275:0.002820:0.006089:0.007471:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.002820:0.005416:0.009245:0.007396:0.002820:0.014306:0.007601:0.007433:0.009618:0.002820:0.008871:0.005080:0.002820:0.005080:0.007452:0.007172:0.009376:0.009618:0.004538:0.007452:0.007695:0.004296:0.002820:0.009039:0.009058:0.009133:0.004296:0.004538:0.007452:0.007209:0.005080:0.007396:0.006275:0.003679:0.002820:0.009899:0.006387:0.006089:0.008871:0.006387:0.002820:0.009094:0.007435:0.006238:0.006275:0.002820:0.006089:0.007471:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.003362
s.e.m. of technical duplicates. :@0.117647:0.132715:0.328187:0.132715:0.328187:0.116046:0.117647:0.116046:0.006275:0.003679:0.007153:0.003679:0.014437:0.003679:0.006163:0.008871:0.005080:0.006163:0.005080:0.007452:0.007172:0.009376:0.009618:0.004538:0.007452:0.007695:0.004296:0.006163:0.009039:0.009058:0.009133:0.004296:0.004538:0.007452:0.007209:0.005080:0.007396:0.006275:0.003679:0.003362
(D):@0.330983:0.132715:0.356981:0.132715:0.356981:0.115425:0.330983:0.115425:0.006238:0.013522:0.006238
 Heat map of Euclidean distance, based on AUC row Z-score values, :@0.356981:0.132715:0.856313:0.132715:0.856313:0.116046:0.356981:0.116046:0.006163:0.013260:0.007599:0.007209:0.005267:0.006163:0.014381:0.007209:0.009226:0.006163:0.008871:0.005080:0.006163:0.009413:0.009282:0.007172:0.004296:0.004538:0.009264:0.007601:0.007433:0.009618:0.006163:0.009320:0.004594:0.006145:0.005360:0.007433:0.009488:0.007359:0.007153:0.003679:0.006163:0.009094:0.007601:0.006443:0.007452:0.009320:0.006163:0.008871:0.009618:0.006163:0.011056:0.013111:0.012009:0.006163:0.006089:0.008890:0.012046:0.006163:0.010608:0.006163:0.006443:0.007359:0.008871:0.006089:0.007396:0.006163:0.008050:0.007697:0.004014:0.009284:0.007396:0.006275:0.003679:0.003362
showing organoid response to a panel of drugs, including PI3K/AKT/mTOR pathway, PARP and Wee1 :@0.117647:0.147267:0.856400:0.147267:0.856400:0.130598:0.117647:0.130598:0.006182:0.009245:0.008890:0.012046:0.004594:0.009376:0.008068:0.005640:0.008873:0.006238:0.008068:0.007431:0.009490:0.008871:0.004538:0.009320:0.005640:0.006089:0.007396:0.006145:0.009413:0.008871:0.009506:0.006443:0.007396:0.005640:0.005080:0.009039:0.005640:0.007601:0.005640:0.009301:0.007433:0.009488:0.007321:0.004296:0.005640:0.008873:0.005080:0.005640:0.009320:0.006518:0.009338:0.007956:0.006275:0.003679:0.005640:0.004594:0.009488:0.007172:0.004015:0.009282:0.009320:0.004594:0.009376:0.008068:0.005640:0.009544:0.005939:0.008535:0.011897:0.005808:0.012214:0.011897:0.010926:0.005808:0.012810:0.010685:0.013130:0.010944:0.005640:0.009301:0.007209:0.005416:0.009058:0.012046:0.007302:0.006537:0.003679:0.005640:0.008386:0.012214:0.010944:0.009955:0.005640:0.007433:0.009490:0.009320:0.005640:0.015259:0.007452:0.007396:0.008535:0.003362
inhibitors. n = 18 distinct organoid lines. NT, not tested. :@0.117647:0.161819:0.507460:0.161819:0.507460:0.145151:0.117647:0.145151:0.004594:0.009712:0.009376:0.004538:0.008853:0.004314:0.005080:0.008871:0.006238:0.006275:0.003679:0.003829:0.009618:0.003829:0.009637:0.003829:0.008535:0.008535:0.003829:0.009320:0.004594:0.006145:0.005267:0.004594:0.009488:0.007450:0.005267:0.003829:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.003829:0.004296:0.004594:0.009488:0.007396:0.006275:0.003679:0.003829:0.013279:0.008965:0.003679:0.003829:0.009488:0.008853:0.005267:0.003829:0.005080:0.007396:0.006145:0.005080:0.007452:0.009095:0.003679:0.003362
(E):@0.507966:0.161819:0.530620:0.161819:0.530620:0.144529:0.507966:0.144529:0.006238:0.010179:0.006238
 Top, dose–response curves for niraparib show :@0.530620:0.161819:0.856282:0.161819:0.856282:0.145151:0.530620:0.145151:0.003829:0.008890:0.008853:0.008591:0.003679:0.003829:0.009264:0.008965:0.006443:0.007396:0.009656:0.006089:0.007396:0.006145:0.009413:0.008871:0.009506:0.006443:0.007396:0.003829:0.007452:0.009338:0.006871:0.007883:0.007396:0.006275:0.003829:0.004931:0.008871:0.006387:0.003829:0.009618:0.004594:0.006462:0.007209:0.009299:0.007435:0.006387:0.004538:0.009021:0.003829:0.006182:0.009245:0.008890:0.012046:0.003362
differential response between organoid lines. Dots represent the mean of technical duplicates. Error bars :@0.117647:0.176371:0.856320:0.176371:0.856320:0.159702:0.117647:0.159702:0.009320:0.004594:0.004884:0.004734:0.007396:0.006089:0.007396:0.009320:0.005267:0.004744:0.007695:0.004296:0.005061:0.006089:0.007396:0.006145:0.009413:0.008871:0.009506:0.006443:0.007396:0.005061:0.009207:0.007471:0.005267:0.011878:0.007452:0.007396:0.009618:0.005061:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.005061:0.004296:0.004594:0.009488:0.007396:0.006275:0.003679:0.005061:0.013279:0.008853:0.005267:0.006275:0.005061:0.006089:0.007471:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.005061:0.005416:0.009245:0.007396:0.005061:0.014306:0.007601:0.007433:0.009618:0.005061:0.008871:0.005080:0.005061:0.005080:0.007452:0.007172:0.009376:0.009618:0.004538:0.007452:0.007695:0.004296:0.005061:0.009039:0.009058:0.009133:0.004296:0.004538:0.007452:0.007209:0.005080:0.007396:0.006275:0.003679:0.005061:0.009899:0.006387:0.006089:0.008871:0.006387:0.005061:0.009095:0.007433:0.006238:0.006275:0.003362
represent s.e.m. of technical duplicates. Bottom, box-and-whisker plot (minimum to maximum) presenting :@0.117647:0.190923:0.856241:0.190923:0.856241:0.174255:0.117647:0.174255:0.006089:0.007471:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.003287:0.006275:0.003679:0.007153:0.003679:0.014437:0.003679:0.003287:0.008871:0.005080:0.003287:0.005080:0.007452:0.007172:0.009376:0.009618:0.004538:0.007452:0.007693:0.004296:0.003287:0.009039:0.009058:0.009133:0.004296:0.004538:0.007452:0.007209:0.005080:0.007396:0.006275:0.003679:0.003287:0.010702:0.008853:0.005043:0.005080:0.008871:0.014437:0.003679:0.003287:0.009207:0.008853:0.008255:0.006163:0.007433:0.009488:0.009320:0.006163:0.012100:0.009376:0.004594:0.006182:0.008404:0.007396:0.006387:0.003287:0.009133:0.004240:0.008853:0.005267:0.003287:0.005678:0.014437:0.004594:0.009618:0.004594:0.014138:0.009338:0.014437:0.003287:0.005080:0.009039:0.003287:0.014381:0.007601:0.008255:0.004594:0.014138:0.009338:0.014437:0.005678:0.003287:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.004594:0.009376:0.008068:0.003362
RAD51 foci score after radiation. Each point represents percentage of RAD51+ cells within geminin+ :@0.117647:0.205476:0.856196:0.205476:0.856196:0.188807:0.117647:0.188807:0.011169:0.012214:0.013204:0.008535:0.008535:0.006387:0.004931:0.009224:0.007359:0.004594:0.006387:0.006443:0.007359:0.008871:0.006089:0.007396:0.006387:0.007435:0.005071:0.004884:0.007396:0.006387:0.006387:0.006462:0.007601:0.009320:0.004742:0.007209:0.005267:0.004538:0.008871:0.009618:0.003679:0.006387:0.010121:0.007601:0.007172:0.009376:0.006387:0.009411:0.008871:0.004594:0.009320:0.005267:0.006387:0.006089:0.007469:0.009060:0.006089:0.007396:0.006442:0.007396:0.009320:0.005267:0.006275:0.006387:0.009411:0.007396:0.006089:0.007359:0.007396:0.009320:0.005360:0.007527:0.007900:0.007396:0.006387:0.008871:0.005080:0.006387:0.011167:0.012214:0.013204:0.008535:0.008535:0.009637:0.006387:0.007359:0.007321:0.004408:0.004296:0.006275:0.006387:0.012046:0.004314:0.005416:0.009376:0.004594:0.009618:0.006387:0.007900:0.007396:0.014437:0.004594:0.009618:0.004594:0.009618:0.009637:0.003362
(GMN+) cell population in one organoid. Horizontal bars and ‘+’ represent median and mean of all dots, :@0.117647:0.220027:0.856376:0.220027:0.856376:0.203359:0.117647:0.203359:0.005678:0.012831:0.016043:0.013279:0.009637:0.005678:0.004482:0.007359:0.007321:0.004408:0.004296:0.004482:0.009413:0.008851:0.009041:0.009448:0.004445:0.007209:0.005267:0.004538:0.008871:0.009618:0.004482:0.004594:0.009618:0.004482:0.008871:0.009488:0.007396:0.004482:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009095:0.003679:0.004482:0.013260:0.008871:0.006387:0.004594:0.007228:0.008871:0.009320:0.005360:0.007695:0.004296:0.004482:0.009094:0.007435:0.006238:0.006275:0.004482:0.007433:0.009490:0.009320:0.004482:0.003567:0.009637:0.003511:0.004482:0.006089:0.007469:0.009060:0.006089:0.007396:0.006442:0.007396:0.009320:0.005267:0.004482:0.014306:0.007452:0.009320:0.004744:0.007433:0.009618:0.004482:0.007433:0.009488:0.009320:0.004482:0.014308:0.007599:0.007435:0.009618:0.004482:0.008871:0.005080:0.004482:0.007695:0.004408:0.004296:0.004482:0.009264:0.008853:0.005267:0.006275:0.003679:0.003362
respectively. Empty and full dots show results of two biologically independent experiments conducted :@0.117647:0.234580:0.856393:0.234580:0.856393:0.217911:0.117647:0.217911:0.006089:0.007396:0.006145:0.009413:0.007452:0.007452:0.005267:0.004538:0.007881:0.007321:0.004240:0.006537:0.003679:0.006462:0.009899:0.014138:0.009039:0.005267:0.007956:0.006462:0.007433:0.009488:0.009320:0.006462:0.005211:0.009450:0.004408:0.004296:0.006462:0.009264:0.008853:0.005267:0.006275:0.006462:0.006182:0.009245:0.008890:0.012046:0.006462:0.006089:0.007396:0.006145:0.009450:0.004015:0.005267:0.006275:0.006462:0.008871:0.005080:0.006462:0.005267:0.011878:0.009039:0.006462:0.008853:0.004538:0.008946:0.004240:0.009039:0.008068:0.004538:0.007452:0.007693:0.004408:0.004240:0.007956:0.006462:0.004594:0.009490:0.009262:0.007471:0.009413:0.007396:0.009488:0.009264:0.007396:0.009320:0.005267:0.006462:0.007452:0.008255:0.009413:0.007396:0.006387:0.004594:0.014306:0.007396:0.009320:0.005267:0.006275:0.006462:0.007359:0.008871:0.009488:0.009039:0.009282:0.007452:0.005080:0.007452:0.009320:0.003362
one or two passages apart. Total number (n) of analyzed geminin+ cells in each organoid line is presented. :@0.117647:0.249132:0.856170:0.249132:0.856170:0.232463:0.117647:0.232463:0.008871:0.009488:0.007396:0.004071:0.008871:0.006387:0.004071:0.005267:0.011878:0.009039:0.004071:0.009301:0.007601:0.006163:0.006499:0.007527:0.007900:0.007396:0.006275:0.004071:0.007209:0.009301:0.007433:0.006518:0.005267:0.003679:0.004071:0.008890:0.008853:0.005360:0.007695:0.004296:0.004071:0.009320:0.009338:0.014233:0.009206:0.007396:0.006387:0.004071:0.005678:0.009618:0.005678:0.004071:0.008871:0.005080:0.004071:0.007433:0.009562:0.007695:0.004240:0.007956:0.007228:0.007452:0.009320:0.004071:0.007900:0.007396:0.014437:0.004594:0.009618:0.004594:0.009618:0.009637:0.004071:0.007359:0.007321:0.004408:0.004296:0.006275:0.004071:0.004594:0.009618:0.004071:0.007601:0.007601:0.007172:0.009376:0.004071:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.004071:0.004296:0.004594:0.009488:0.007396:0.004071:0.004594:0.006275:0.004071:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005080:0.007452:0.009095:0.003679:0.003362
(F):@0.117647:0.263684:0.139853:0.263684:0.139853:0.246393:0.117647:0.246393:0.006238:0.009730:0.006238
 Histological analysis of organoid-derived xenograft (HGS-3.1) following orthotopic transplantation :@0.139853:0.263684:0.856301:0.263684:0.856301:0.247015:0.139853:0.247015:0.006238:0.013484:0.004594:0.006145:0.005080:0.008946:0.004240:0.009039:0.008068:0.004538:0.007452:0.007695:0.004296:0.006238:0.007433:0.009562:0.007695:0.004240:0.007956:0.006219:0.004594:0.006275:0.006238:0.008871:0.005080:0.006238:0.008873:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006163:0.009264:0.007396:0.006387:0.004537:0.007881:0.007452:0.009320:0.006238:0.008087:0.007396:0.009488:0.009039:0.008068:0.006460:0.007435:0.005071:0.005071:0.006238:0.005678:0.013428:0.012831:0.008274:0.006163:0.008535:0.003679:0.008535:0.005678:0.006238:0.004931:0.008946:0.004408:0.004240:0.008890:0.012046:0.004594:0.009376:0.008068:0.006238:0.008871:0.006518:0.005416:0.009245:0.008853:0.005080:0.008853:0.009058:0.004538:0.007359:0.006238:0.005267:0.006462:0.007433:0.009506:0.006145:0.009133:0.004445:0.007433:0.009320:0.005360:0.007209:0.005267:0.004538:0.008871:0.009618:0.003362
into the mouse bursa. Tumor cells have invaded into the mouse ovary and H&E staining (left) shows solid :@0.117647:0.278236:0.856415:0.278236:0.856415:0.261567:0.117647:0.261567:0.004594:0.009320:0.005080:0.009039:0.004053:0.005416:0.009247:0.007396:0.004053:0.014306:0.008853:0.009338:0.006443:0.007396:0.004053:0.008836:0.009338:0.006238:0.006498:0.007601:0.003679:0.004053:0.008927:0.009338:0.014306:0.008871:0.006387:0.004053:0.007359:0.007319:0.004408:0.004296:0.006275:0.004053:0.009320:0.007302:0.007881:0.007396:0.004053:0.004594:0.009301:0.008050:0.007601:0.009264:0.007452:0.009320:0.004053:0.004594:0.009320:0.005080:0.009039:0.004053:0.005416:0.009245:0.007396:0.004053:0.014306:0.008853:0.009338:0.006443:0.007396:0.004053:0.008890:0.008050:0.007433:0.006873:0.007956:0.004053:0.007433:0.009488:0.009320:0.004053:0.013783:0.012868:0.009899:0.004053:0.006145:0.005360:0.007433:0.004594:0.009618:0.004594:0.009376:0.008068:0.004053:0.005678:0.004240:0.007396:0.005071:0.005071:0.005678:0.004053:0.006182:0.009245:0.008890:0.012046:0.006275:0.004053:0.006442:0.008948:0.004296:0.004540:0.009320:0.003362
pattern with indications for slit-like spaces (arrow) as well as pleomorphic cells with prominent nuclear :@0.117647:0.292788:0.856355:0.292788:0.856355:0.276119:0.117647:0.276119:0.009301:0.007209:0.005043:0.005080:0.007396:0.006387:0.009618:0.005528:0.012046:0.004314:0.005416:0.009376:0.005528:0.004594:0.009488:0.009320:0.004538:0.007452:0.007209:0.005267:0.004538:0.008871:0.009506:0.006275:0.005528:0.004931:0.008871:0.006387:0.005528:0.006182:0.004296:0.004314:0.005267:0.006163:0.004296:0.004705:0.008404:0.007396:0.005528:0.006146:0.009299:0.007601:0.007359:0.007396:0.006275:0.005528:0.005678:0.007433:0.006387:0.006089:0.008890:0.012046:0.005678:0.005528:0.007601:0.006275:0.005528:0.011878:0.007321:0.004408:0.004296:0.005528:0.007601:0.006275:0.005528:0.009133:0.004240:0.007452:0.008871:0.014306:0.008871:0.006518:0.009133:0.009376:0.004538:0.007359:0.005528:0.007359:0.007321:0.004408:0.004296:0.006275:0.005528:0.012046:0.004314:0.005416:0.009376:0.005528:0.009058:0.006089:0.008871:0.014437:0.004594:0.009488:0.007396:0.009320:0.005267:0.005528:0.009320:0.009282:0.007172:0.004240:0.007601:0.007433:0.006387:0.003362
atypia. Xenograft has maintained PAX8-positive staining (right). A summary of organoid-derived xenograft :@0.117647:0.307340:0.854850:0.307340:0.854850:0.290671:0.117647:0.290671:0.007209:0.005267:0.007956:0.009058:0.004744:0.007601:0.003679:0.003026:0.011299:0.007396:0.009488:0.009039:0.008068:0.006462:0.007433:0.005071:0.005071:0.003026:0.009320:0.007601:0.006275:0.003026:0.014381:0.007433:0.004594:0.009320:0.005360:0.007433:0.004594:0.009488:0.007452:0.009320:0.003026:0.008386:0.012289:0.011542:0.008535:0.006163:0.009411:0.008965:0.006219:0.004314:0.005267:0.004538:0.007881:0.007396:0.003026:0.006145:0.005360:0.007433:0.004594:0.009618:0.004594:0.009376:0.008068:0.003026:0.005678:0.006387:0.004594:0.008124:0.009077:0.005267:0.005678:0.003679:0.003026:0.012214:0.003026:0.006145:0.009338:0.014437:0.014381:0.007433:0.006873:0.007956:0.003026:0.008873:0.005080:0.003026:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006163:0.009264:0.007396:0.006387:0.004538:0.007881:0.007452:0.009320:0.003026:0.008087:0.007396:0.009490:0.009039:0.008068:0.006462:0.007433:0.005071:0.003562:0.003362
experiments is presented in Supplementary Table 8. Scale bar, 0.5 mm. :@0.117647:0.321892:0.598265:0.321892:0.598265:0.305223:0.117647:0.305223:0.007452:0.008255:0.009413:0.007396:0.006387:0.004594:0.014304:0.007396:0.009320:0.005267:0.006275:0.002988:0.004594:0.006275:0.002979:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005080:0.007452:0.009320:0.002979:0.004594:0.009618:0.002979:0.008014:0.009056:0.009039:0.009133:0.004240:0.007396:0.014308:0.007396:0.009320:0.005358:0.007433:0.006873:0.007956:0.002988:0.008927:0.007452:0.008927:0.004240:0.007396:0.002979:0.008535:0.003679:0.002979:0.008666:0.007452:0.007695:0.004240:0.007396:0.002979:0.009095:0.007433:0.005117:0.003679:0.002979:0.008535:0.003679:0.008535:0.002979:0.014437:0.014437:0.003679:0.003362
(G) :@0.597868:0.321892:0.626648:0.321892:0.626648:0.304602:0.597868:0.304602:0.006238:0.013017:0.006238:0.003287
Gemcitabine-sensitive organoids :@0.626274:0.321892:0.856310:0.321892:0.856310:0.305223:0.626274:0.305223:0.012943:0.007396:0.014306:0.007359:0.004314:0.005360:0.007452:0.008853:0.004594:0.009488:0.007396:0.006163:0.006442:0.007396:0.009506:0.006219:0.004314:0.005267:0.004538:0.007881:0.007396:0.002988:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006275:0.003362
were subcutaneously injected into immunodeficient mice and tumor size was monitored. Once the tumor :@0.117647:0.336444:0.856396:0.336444:0.856396:0.319776:0.117647:0.319776:0.011878:0.007396:0.006089:0.007396:0.004221:0.006145:0.009282:0.009207:0.007452:0.009058:0.005360:0.007433:0.009488:0.007452:0.008853:0.009338:0.006182:0.004240:0.007956:0.004221:0.004594:0.009320:0.004370:0.007452:0.007452:0.005080:0.007452:0.009320:0.004221:0.004594:0.009320:0.005080:0.009039:0.004221:0.004594:0.014437:0.014138:0.009338:0.009488:0.009226:0.009264:0.007396:0.004650:0.004594:0.007359:0.004538:0.007396:0.009320:0.005267:0.004221:0.014437:0.004538:0.007359:0.007396:0.004221:0.007433:0.009488:0.009320:0.004221:0.005043:0.009338:0.014306:0.008871:0.006387:0.004221:0.006219:0.004594:0.007228:0.007396:0.004221:0.012046:0.007601:0.006275:0.004221:0.014306:0.008871:0.009618:0.004314:0.005080:0.008871:0.006089:0.007452:0.009095:0.003679:0.004221:0.013335:0.009490:0.007359:0.007396:0.004221:0.005416:0.009245:0.007396:0.004221:0.005043:0.009338:0.014306:0.008871:0.006387:0.003362
reached 50 mm3, mice were randomly selected and treated with intraperitoneal injections of gemcitabine (2 :@0.117647:0.350996:0.856355:0.350996:0.856355:0.334327:0.117647:0.334327:0.006089:0.007601:0.007601:0.007172:0.009245:0.007452:0.009320:0.003156:0.008535:0.008535:0.003156:0.014437:0.014437:0.008535:0.003679:0.003156:0.014437:0.004538:0.007359:0.007396:0.003156:0.011878:0.007396:0.006089:0.007396:0.003156:0.006462:0.007433:0.009488:0.009264:0.008871:0.014530:0.004240:0.007956:0.003156:0.006443:0.007321:0.004240:0.007452:0.007452:0.005080:0.007452:0.009320:0.003156:0.007433:0.009488:0.009320:0.003156:0.005267:0.006089:0.007601:0.007209:0.005080:0.007452:0.009320:0.003156:0.012046:0.004314:0.005416:0.009376:0.003156:0.004594:0.009320:0.005267:0.006462:0.007209:0.009413:0.007396:0.006387:0.004312:0.005082:0.008871:0.009488:0.007601:0.007693:0.004296:0.003156:0.004594:0.009320:0.004370:0.007452:0.007452:0.005267:0.004538:0.008871:0.009506:0.006275:0.003156:0.008871:0.005080:0.003156:0.007900:0.007396:0.014306:0.007359:0.004314:0.005360:0.007452:0.008853:0.004594:0.009488:0.007396:0.003156:0.005678:0.008535:0.003362
mg per kg body weight) (n = 7 independent mice) or vehicle (n = 9 independent mice), 5 times per week for :@0.117647:0.365548:0.856150:0.365548:0.856150:0.348880:0.117647:0.348880:0.014194:0.008068:0.003380:0.009413:0.007396:0.006387:0.003380:0.008610:0.008068:0.003380:0.009206:0.009226:0.009264:0.007956:0.003380:0.011878:0.007396:0.004594:0.008124:0.009077:0.005267:0.005678:0.003380:0.005678:0.009618:0.003380:0.009637:0.003380:0.008535:0.003380:0.004594:0.009488:0.009264:0.007471:0.009413:0.007396:0.009488:0.009264:0.007396:0.009320:0.005267:0.003380:0.014437:0.004538:0.007359:0.007396:0.005678:0.003380:0.008871:0.006387:0.003380:0.007883:0.007321:0.009376:0.004538:0.007172:0.004240:0.007396:0.003380:0.005678:0.009618:0.003380:0.009637:0.003380:0.008535:0.003380:0.004594:0.009488:0.009264:0.007471:0.009413:0.007396:0.009488:0.009264:0.007396:0.009320:0.005267:0.003380:0.014437:0.004538:0.007359:0.007396:0.005678:0.003679:0.003380:0.008535:0.003380:0.005267:0.004594:0.014306:0.007396:0.006275:0.003380:0.009413:0.007396:0.006387:0.003380:0.011878:0.007450:0.007321:0.008610:0.003380:0.004931:0.008871:0.006387:0.003362
4 consecutive weeks (in total 20 injections). Left, an example of tumor growth over time in a vehicle (white :@0.117647:0.380101:0.856376:0.380101:0.856376:0.363432:0.117647:0.363432:0.008535:0.003847:0.007359:0.008871:0.009506:0.006443:0.007452:0.007452:0.009056:0.005267:0.004538:0.007883:0.007396:0.003847:0.011878:0.007452:0.007319:0.008610:0.006275:0.003847:0.005678:0.004594:0.009618:0.003847:0.005080:0.008853:0.005360:0.007695:0.004296:0.003847:0.008535:0.008535:0.003847:0.004594:0.009320:0.004370:0.007452:0.007452:0.005267:0.004538:0.008871:0.009506:0.006275:0.005678:0.003679:0.003847:0.009674:0.007396:0.005071:0.005071:0.003679:0.003847:0.007435:0.009618:0.003847:0.007450:0.008255:0.007433:0.014138:0.009133:0.004240:0.007396:0.003847:0.008871:0.005080:0.003847:0.005043:0.009338:0.014308:0.008871:0.006387:0.003847:0.008068:0.006089:0.008890:0.012046:0.005416:0.009376:0.003847:0.008890:0.007881:0.007396:0.006387:0.003847:0.005267:0.004594:0.014306:0.007396:0.003847:0.004594:0.009618:0.003847:0.007601:0.003847:0.007881:0.007321:0.009376:0.004538:0.007172:0.004240:0.007396:0.003847:0.005678:0.012102:0.009376:0.004314:0.005080:0.007396:0.003362
dots) and a gemcitabine-treated (black dots) mouse. Right, box-and-whisker plot (minimum to maximum) :@0.117647:0.394653:0.856307:0.394653:0.856307:0.377984:0.117647:0.377984:0.009264:0.008853:0.005267:0.006275:0.005678:0.003500:0.007433:0.009490:0.009320:0.003500:0.007601:0.003502:0.007900:0.007396:0.014306:0.007359:0.004314:0.005358:0.007452:0.008853:0.004594:0.009488:0.007396:0.006163:0.005267:0.006089:0.007601:0.007209:0.005080:0.007452:0.009320:0.003500:0.005678:0.008927:0.004445:0.007601:0.007172:0.008610:0.003502:0.009264:0.008853:0.005267:0.006275:0.005678:0.003500:0.014306:0.008853:0.009338:0.006443:0.007153:0.003679:0.003502:0.011036:0.004594:0.008124:0.009077:0.005267:0.003679:0.003502:0.009207:0.008853:0.008255:0.006163:0.007431:0.009490:0.009320:0.006163:0.012100:0.009376:0.004594:0.006182:0.008404:0.007396:0.006387:0.003502:0.009133:0.004240:0.008853:0.005267:0.003500:0.005678:0.014437:0.004594:0.009618:0.004594:0.014138:0.009338:0.014437:0.003500:0.005080:0.009039:0.003502:0.014381:0.007601:0.008255:0.004594:0.014140:0.009338:0.014437:0.005678:0.003362
summarizing the results across all vehicle and gemcitabine-treated mice, showing tumor size at day 55. :@0.117647:0.409205:0.856303:0.409205:0.856303:0.392536:0.117647:0.392536:0.006145:0.009338:0.014437:0.014381:0.007433:0.006387:0.004594:0.007228:0.004594:0.009376:0.008068:0.005864:0.005416:0.009245:0.007396:0.005864:0.006089:0.007396:0.006145:0.009450:0.004015:0.005267:0.006275:0.005864:0.007601:0.007359:0.006089:0.008965:0.006163:0.006275:0.005864:0.007695:0.004408:0.004296:0.005864:0.007881:0.007321:0.009376:0.004538:0.007172:0.004240:0.007396:0.005864:0.007433:0.009490:0.009320:0.005864:0.007900:0.007396:0.014306:0.007359:0.004314:0.005360:0.007452:0.008853:0.004594:0.009486:0.007396:0.006163:0.005267:0.006089:0.007601:0.007209:0.005080:0.007452:0.009320:0.005864:0.014437:0.004538:0.007359:0.007153:0.003679:0.005864:0.006182:0.009245:0.008890:0.012046:0.004594:0.009376:0.008068:0.005864:0.005043:0.009338:0.014306:0.008873:0.006387:0.005864:0.006219:0.004594:0.007228:0.007396:0.005864:0.007209:0.005267:0.005864:0.009469:0.007302:0.007956:0.005864:0.008535:0.008535:0.003679:0.003362
Horizontal bars and ‘+’ :@0.117647:0.425374:0.278974:0.425374:0.278974:0.408705:0.117647:0.408705:0.013260:0.008871:0.006387:0.004594:0.007228:0.008871:0.009320:0.005360:0.007695:0.004296:0.003362:0.009094:0.007433:0.006238:0.006275:0.003362:0.007433:0.009490:0.009320:0.003362:0.003567:0.009637:0.003511:0.003362
represent the median:@0.278973:0.425374:0.425153:0.425374:0.425153:0.408705:0.278973:0.408705:0.006089:0.007471:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.003362:0.005416:0.009245:0.007396:0.003362:0.014306:0.007452:0.009320:0.004742:0.007435:0.009618
 and mean of all dots, respectively. *P < 0.001, t-test.:@0.425152:0.425374:0.777652:0.425374:0.777652:0.408705:0.425152:0.408705:0.003362:0.007433:0.009488:0.009320:0.003362:0.014306:0.007601:0.007433:0.009618:0.003362:0.008871:0.005080:0.003362:0.007695:0.004408:0.004296:0.003362:0.009264:0.008851:0.005267:0.006275:0.003679:0.003362:0.006089:0.007396:0.006145:0.009413:0.007452:0.007452:0.005267:0.004538:0.007881:0.007321:0.004240:0.006537:0.003679:0.003362:0.006686:0.009955:0.003362:0.009450:0.003362:0.008535:0.003679:0.008535:0.008535:0.008535:0.003679:0.003362:0.005267:0.006163:0.005082:0.007396:0.006145:0.005267:0.003679
Discussion:@0.117647:0.485480:0.232229:0.485480:0.232229:0.457369:0.117647:0.457369:0.013103:0.006217:0.012144:0.012841:0.013015:0.012144:0.012144:0.006217:0.013132:0.013626
Developing reliable experimental models that address clinical challenges, such as early :@0.117647:0.527329:0.857118:0.527329:0.857118:0.506956:0.117647:0.506956:0.016230:0.009336:0.009633:0.008948:0.005182:0.010820:0.011071:0.005615:0.011459:0.009861:0.005524:0.007442:0.008948:0.005250:0.005798:0.009108:0.010911:0.005182:0.009039:0.005524:0.009108:0.010089:0.011502:0.009039:0.007807:0.005615:0.017485:0.009039:0.011391:0.006551:0.009405:0.005250:0.005524:0.017485:0.011276:0.011322:0.008948:0.005250:0.007670:0.005524:0.006620:0.011391:0.008811:0.006437:0.005524:0.009291:0.011322:0.011391:0.007442:0.009039:0.007533:0.007670:0.005524:0.008765:0.005250:0.005615:0.011756:0.005547:0.009108:0.009405:0.005250:0.005524:0.008765:0.011391:0.009405:0.005387:0.005182:0.009039:0.011459:0.009656:0.009039:0.007670:0.004497:0.005524:0.007510:0.011345:0.008765:0.011459:0.005524:0.009291:0.007670:0.005524:0.009291:0.009085:0.007601:0.005182:0.009724:0.004109
detection, tumor recurrence and acquired chemotherapy resistance, is a high priority in :@0.117647:0.547908:0.857144:0.547908:0.857144:0.527535:0.117647:0.527535:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.004497:0.004474:0.006163:0.011413:0.017485:0.010843:0.007807:0.004474:0.007442:0.009108:0.009108:0.011413:0.007807:0.007442:0.009039:0.011596:0.008994:0.009039:0.004474:0.009085:0.011596:0.011391:0.004474:0.009291:0.008994:0.010706:0.011413:0.005615:0.007442:0.009108:0.011391:0.004474:0.008765:0.011299:0.009039:0.017485:0.010820:0.006620:0.011299:0.009039:0.007898:0.008811:0.011094:0.009724:0.004474:0.007442:0.009039:0.007601:0.005615:0.007510:0.006551:0.009085:0.011596:0.008994:0.008743:0.004497:0.004474:0.005615:0.007670:0.004474:0.009291:0.004474:0.011459:0.005615:0.009930:0.011459:0.004474:0.011071:0.007807:0.005547:0.010843:0.007807:0.005273:0.006437:0.009724:0.004474:0.005615:0.011756:0.004109
OC research . In this study, we describe an organoid platform that enables long-term :@0.117647:0.568487:0.835013:0.568487:0.835013:0.548114:0.117647:0.548114:0.016778:0.014678:0.004018:0.007442:0.009039:0.007875:0.009291:0.009085:0.007442:0.008765:0.011459:0.012157:0.004497:0.004018:0.006894:0.011756:0.004018:0.006620:0.011459:0.005615:0.007670:0.004018:0.007510:0.006163:0.011345:0.011322:0.007989:0.004497:0.004018:0.014518:0.009039:0.004018:0.011322:0.009039:0.007875:0.008994:0.007807:0.005547:0.011251:0.009039:0.004018:0.009085:0.011756:0.004018:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.004018:0.011162:0.005433:0.008811:0.006437:0.006026:0.010843:0.007807:0.017645:0.004018:0.006620:0.011391:0.008811:0.006437:0.004018:0.009039:0.011687:0.009108:0.010911:0.005182:0.009039:0.007670:0.004018:0.005182:0.010843:0.011459:0.009861:0.007533:0.006209:0.009039:0.007807:0.017645:0.004109
73:@0.223512:0.560871:0.235675:0.560871:0.235675:0.548993:0.223512:0.548993:0.006082:0.006082
in :@0.834862:0.568956:0.858168:0.568956:0.858168:0.546934:0.834862:0.546934:0.005935:0.012144:0.005227
vitro:@0.117647:0.589534:0.159511:0.589534:0.159511:0.567512:0.117647:0.567512:0.010500:0.005912:0.006802:0.007921:0.010729
 expansion, manipulation and analysis of a wide variety of OC subtypes. A compre-:@0.159511:0.589066:0.852941:0.589066:0.852941:0.568693:0.159511:0.568693:0.003858:0.009108:0.010089:0.011368:0.009085:0.011619:0.007601:0.005547:0.010843:0.011756:0.004497:0.003858:0.017577:0.009085:0.011756:0.005273:0.011048:0.011550:0.005430:0.008811:0.006437:0.005547:0.010843:0.011756:0.003858:0.009085:0.011596:0.011391:0.003858:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.003858:0.010843:0.006209:0.003858:0.009291:0.003858:0.014723:0.005547:0.011322:0.009039:0.003858:0.009838:0.009085:0.007807:0.005547:0.009131:0.006437:0.009724:0.003858:0.010843:0.006209:0.003858:0.016778:0.014678:0.003858:0.007510:0.011345:0.010797:0.006437:0.009724:0.011505:0.009039:0.007670:0.004497:0.003858:0.014929:0.003858:0.008994:0.010843:0.017280:0.011073:0.007442:0.008946:0.007533
hensive analysis demonstrates that OC organoids maintain tumor histological charac-:@0.117647:0.609644:0.852941:0.609644:0.852941:0.589271:0.117647:0.589271:0.011299:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.005775:0.009085:0.011690:0.009402:0.005182:0.009724:0.007601:0.005615:0.007670:0.005775:0.011322:0.009039:0.017485:0.010843:0.011621:0.007510:0.006437:0.007898:0.008811:0.006209:0.009039:0.007670:0.005775:0.006620:0.011391:0.008811:0.006437:0.005775:0.016778:0.014678:0.005775:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.005775:0.017577:0.009085:0.005615:0.011391:0.006551:0.009085:0.005615:0.011756:0.005775:0.006163:0.011413:0.017485:0.010843:0.007807:0.005775:0.011459:0.005615:0.007510:0.006209:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.005775:0.008765:0.011391:0.009085:0.007898:0.009291:0.009035:0.007533
teristics, such as nuclear and cellular atypia, and biomarker expression, such as p53 and :@0.117647:0.630223:0.856961:0.630223:0.856961:0.609850:0.117647:0.609850:0.006209:0.009039:0.007807:0.005615:0.007510:0.006437:0.005547:0.008994:0.007670:0.004497:0.004748:0.007510:0.011345:0.008765:0.011459:0.004748:0.009291:0.007670:0.004748:0.011391:0.011345:0.008765:0.005182:0.009291:0.009085:0.007807:0.004748:0.009085:0.011596:0.011391:0.004748:0.008994:0.008948:0.005387:0.004908:0.011550:0.005433:0.009085:0.007807:0.004748:0.008811:0.006437:0.009724:0.011071:0.005798:0.009291:0.004497:0.004748:0.009085:0.011596:0.011391:0.004748:0.010820:0.005547:0.010843:0.017577:0.009085:0.007601:0.010272:0.009039:0.007807:0.004748:0.009108:0.010089:0.011071:0.007442:0.009039:0.007533:0.007601:0.005547:0.010843:0.011756:0.004497:0.004748:0.007510:0.011345:0.008765:0.011459:0.004748:0.009291:0.007670:0.004748:0.011276:0.010432:0.010432:0.004748:0.009085:0.011596:0.011391:0.004109
PAX8. Organoids and corresponding tumors remained highly similar at the genomic :@0.117647:0.650802:0.857011:0.650802:0.857011:0.630429:0.117647:0.630429:0.010249:0.015020:0.014107:0.010432:0.004497:0.006506:0.016298:0.007624:0.009861:0.009087:0.011596:0.010843:0.005547:0.011391:0.007670:0.006506:0.009085:0.011596:0.011391:0.006506:0.008994:0.010843:0.007807:0.007442:0.009039:0.007510:0.011505:0.010843:0.011596:0.011391:0.005615:0.011459:0.009861:0.006506:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.006506:0.007442:0.009039:0.017577:0.009085:0.005615:0.011596:0.009108:0.011391:0.006506:0.011459:0.005615:0.009930:0.011573:0.005182:0.009724:0.006506:0.007604:0.005615:0.017645:0.005752:0.005433:0.009085:0.007807:0.006506:0.008811:0.006437:0.006506:0.006620:0.011299:0.009039:0.006506:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.004109
level, even after extended passaging. Furthermore, organoids recapitulated OC hall-:@0.117647:0.671380:0.852941:0.671380:0.852941:0.651007:0.117647:0.651007:0.005182:0.009336:0.009633:0.008948:0.004976:0.004497:0.008035:0.009336:0.009633:0.009039:0.011756:0.008035:0.009085:0.006197:0.005969:0.009039:0.007807:0.008035:0.009108:0.010089:0.006209:0.009039:0.011596:0.011322:0.009108:0.011391:0.008035:0.011368:0.009291:0.007533:0.007944:0.009199:0.009861:0.005615:0.011459:0.009679:0.004497:0.008035:0.010729:0.011413:0.007964:0.006620:0.011302:0.009039:0.007807:0.017485:0.010840:0.007442:0.008745:0.004497:0.008035:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.008035:0.007442:0.009108:0.009108:0.008811:0.011071:0.005273:0.006163:0.011550:0.005433:0.008811:0.006209:0.009106:0.011391:0.008035:0.016775:0.014678:0.008035:0.011393:0.009402:0.005387:0.005252:0.007533
marks, such as CNVs, recurrent mutations and tumor heterogeneity. Finally, unsuper-:@0.117647:0.691959:0.852941:0.691959:0.852941:0.671586:0.117647:0.671586:0.017577:0.009085:0.007601:0.010523:0.007670:0.004497:0.005752:0.007510:0.011345:0.008765:0.011459:0.005752:0.009291:0.007670:0.005752:0.014678:0.016230:0.015089:0.007670:0.004497:0.005752:0.007442:0.009108:0.009106:0.011413:0.007807:0.007442:0.009039:0.011391:0.006437:0.005752:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.005752:0.009085:0.011596:0.011391:0.005752:0.006163:0.011413:0.017485:0.010843:0.007807:0.005752:0.011299:0.009131:0.006209:0.009039:0.007442:0.011048:0.009656:0.009039:0.011596:0.009039:0.005273:0.006437:0.007989:0.004497:0.005752:0.011391:0.005615:0.011687:0.009402:0.005387:0.005182:0.007992:0.004497:0.005752:0.011413:0.011619:0.007512:0.011071:0.011502:0.009039:0.007282:0.007533
vised hierarchical clustering of gene expression data grouped the organoids according :@0.117647:0.712538:0.857118:0.712538:0.857118:0.692165:0.117647:0.692165:0.009838:0.005615:0.007875:0.009108:0.011391:0.005981:0.011459:0.005547:0.009039:0.007896:0.009087:0.007442:0.008765:0.011459:0.005547:0.009106:0.009405:0.005250:0.005981:0.008765:0.004908:0.011413:0.007510:0.006209:0.009039:0.007807:0.005615:0.011459:0.009861:0.005981:0.010843:0.006209:0.005981:0.009656:0.009039:0.011596:0.009039:0.005981:0.009108:0.010089:0.011071:0.007442:0.009039:0.007533:0.007601:0.005547:0.010843:0.011756:0.005981:0.011573:0.008811:0.006551:0.009291:0.005981:0.009861:0.007442:0.010820:0.011071:0.011505:0.009108:0.011391:0.005981:0.006620:0.011299:0.009039:0.005981:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.005981:0.009291:0.008994:0.008994:0.010843:0.007442:0.011391:0.005615:0.011459:0.009861:0.004109
to their tumor type and demonstrated that LGS organoids are more similar to normal :@0.117647:0.733116:0.856940:0.733116:0.856940:0.712744:0.117647:0.712744:0.006209:0.011048:0.005638:0.006620:0.011299:0.009039:0.005615:0.007807:0.005638:0.006163:0.011413:0.017485:0.010845:0.007807:0.005638:0.006437:0.009724:0.011505:0.009039:0.005638:0.009085:0.011596:0.011391:0.005638:0.011322:0.009039:0.017485:0.010843:0.011619:0.007510:0.006437:0.007898:0.008811:0.006209:0.009108:0.011391:0.005638:0.006620:0.011391:0.008811:0.006437:0.005638:0.011528:0.015682:0.010112:0.005638:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.005638:0.009085:0.007442:0.009039:0.005638:0.017485:0.010843:0.007442:0.009039:0.005638:0.007601:0.005615:0.017645:0.005752:0.005433:0.009085:0.007807:0.005638:0.006209:0.011048:0.005638:0.011596:0.010843:0.007807:0.017577:0.009405:0.005250:0.004109
samples than are HGS lines. :@0.117647:0.753695:0.355844:0.753695:0.355844:0.733322:0.117647:0.733322:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004109:0.006620:0.011391:0.009085:0.011756:0.004109:0.009085:0.007442:0.009039:0.004109:0.016412:0.015682:0.010112:0.004109:0.005250:0.005615:0.011596:0.009039:0.007670:0.004497:0.004109
During organoid biobanking of normal FT and OSE samples, obtained from risk-reduc-:@0.117647:0.794853:0.852941:0.794853:0.852941:0.774480:0.117647:0.774480:0.016230:0.011413:0.007807:0.005615:0.011459:0.009861:0.003698:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.003698:0.010820:0.005547:0.010957:0.011117:0.009085:0.011870:0.010706:0.005615:0.011459:0.009861:0.003698:0.010843:0.006209:0.003698:0.011598:0.010843:0.007807:0.017577:0.009402:0.005250:0.003698:0.011276:0.013354:0.003698:0.009085:0.011596:0.011391:0.003698:0.016412:0.009768:0.012098:0.003698:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004497:0.003698:0.010957:0.010797:0.006551:0.009085:0.005615:0.011596:0.009108:0.011391:0.003698:0.006414:0.007442:0.010843:0.017645:0.003698:0.007807:0.005615:0.007556:0.010523:0.007533:0.007442:0.009108:0.011048:0.011345:0.009085:0.007533
ing surgeries, we encountered two samples that were apparently malignant: LGS-2 (clin-:@0.117647:0.815431:0.852941:0.815431:0.852941:0.795058:0.117647:0.795058:0.005615:0.011459:0.009861:0.004018:0.007510:0.011413:0.007624:0.009656:0.009039:0.007807:0.005547:0.009039:0.007670:0.004497:0.004018:0.014518:0.009039:0.004018:0.009039:0.011596:0.008994:0.010820:0.011413:0.011391:0.006209:0.009039:0.007442:0.009108:0.011391:0.004018:0.006437:0.014518:0.011048:0.004018:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004018:0.006620:0.011391:0.008811:0.006437:0.004018:0.014520:0.009039:0.007442:0.009039:0.004018:0.008811:0.011048:0.011368:0.009085:0.007442:0.009039:0.011391:0.006620:0.005182:0.009724:0.004018:0.017577:0.009405:0.005250:0.005615:0.009861:0.011687:0.009085:0.011391:0.006437:0.004497:0.004018:0.011528:0.015682:0.010112:0.007533:0.010432:0.004018:0.006939:0.008765:0.005250:0.005615:0.011797:0.007533
ically diagnosed) and OSE(P)7 (indicated by organoid characterization, :@0.117647:0.836010:0.720776:0.836010:0.720776:0.815637:0.117647:0.815637:0.005547:0.009108:0.009405:0.005387:0.005182:0.009724:0.004246:0.011391:0.005798:0.009199:0.009861:0.011596:0.010957:0.007875:0.009108:0.011391:0.006939:0.004246:0.009085:0.011596:0.011391:0.004246:0.016412:0.009768:0.012098:0.006939:0.012167:0.006939:0.010432:0.004246:0.006939:0.005615:0.011596:0.011391:0.005547:0.009108:0.008811:0.006209:0.009108:0.011391:0.004246:0.010843:0.009724:0.004246:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.004246:0.008768:0.011391:0.009085:0.007898:0.009291:0.009108:0.006209:0.009039:0.007807:0.005615:0.008834:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109
Extended Data :@0.720935:0.836010:0.856960:0.836010:0.856960:0.814877:0.720935:0.814877:0.012692:0.010318:0.006871:0.009268:0.012167:0.011961:0.009722:0.011870:0.004154:0.016527:0.009542:0.007056:0.009861:0.004018
Figure 3e,f:@0.117647:0.856589:0.213188:0.856589:0.213188:0.835456:0.117647:0.835456:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004896:0.010911:0.009176:0.005433:0.006939
). Interestingly, unsupervised hierarchical clustering of gene expression data :@0.213189:0.856589:0.857050:0.856589:0.857050:0.836216:0.213189:0.836216:0.006939:0.004497:0.005008:0.006894:0.011391:0.006209:0.009039:0.007442:0.009039:0.007510:0.006437:0.005615:0.011459:0.009930:0.005182:0.007989:0.004497:0.005010:0.011413:0.011619:0.007510:0.011071:0.011505:0.009039:0.008398:0.009838:0.005615:0.007875:0.009108:0.011391:0.005010:0.011459:0.005547:0.009039:0.007896:0.009085:0.007442:0.008768:0.011459:0.005547:0.009106:0.009405:0.005250:0.005010:0.008765:0.004908:0.011413:0.007510:0.006209:0.009039:0.007807:0.005615:0.011459:0.009861:0.005008:0.010843:0.006209:0.005010:0.009656:0.009039:0.011596:0.009039:0.005008:0.009108:0.010089:0.011071:0.007442:0.009039:0.007533:0.007601:0.005547:0.010843:0.011756:0.005008:0.011573:0.008811:0.006551:0.009291:0.004109
grouped these organoid lines together, thus implying biological similarity. Both organoid :@0.117647:0.877167:0.857061:0.877167:0.857061:0.856794:0.117647:0.856794:0.009861:0.007442:0.010820:0.011071:0.011505:0.009108:0.011391:0.003321:0.006620:0.011299:0.009039:0.007873:0.009039:0.003321:0.010845:0.007624:0.009861:0.009083:0.011598:0.010843:0.005547:0.011391:0.003321:0.005250:0.005615:0.011596:0.009039:0.007670:0.003321:0.006209:0.011048:0.009656:0.009131:0.006620:0.011299:0.009039:0.006255:0.004497:0.003321:0.006617:0.011094:0.011413:0.007670:0.003333:0.005615:0.017280:0.011162:0.005179:0.009724:0.005615:0.011459:0.009861:0.003321:0.010820:0.005547:0.010934:0.005184:0.011048:0.009861:0.005545:0.009108:0.009405:0.005250:0.003321:0.007601:0.005615:0.017645:0.005752:0.005433:0.009085:0.007807:0.005273:0.006437:0.007989:0.004497:0.003321:0.013077:0.010820:0.006620:0.011459:0.003321:0.010845:0.007624:0.009861:0.009085:0.011598:0.010843:0.005547:0.011391:0.004109
lines were derived from patients at high risk of developing HGS tumors. Therefore, these :@0.117647:0.897746:0.857144:0.897746:0.857144:0.877373:0.117647:0.877373:0.005250:0.005615:0.011596:0.009039:0.007670:0.003858:0.014518:0.009039:0.007442:0.009039:0.003858:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011391:0.003858:0.006414:0.007442:0.010843:0.017645:0.003858:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.007670:0.003858:0.008811:0.006437:0.003858:0.011459:0.005615:0.009930:0.011459:0.003858:0.007807:0.005615:0.007556:0.010523:0.003858:0.010843:0.006209:0.003858:0.011322:0.009336:0.009633:0.008948:0.005184:0.010820:0.011071:0.005615:0.011457:0.009861:0.003858:0.016412:0.015682:0.010112:0.003858:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.004497:0.003858:0.011470:0.011311:0.009039:0.007442:0.009039:0.006026:0.010843:0.007442:0.008743:0.004497:0.003858:0.006620:0.011299:0.009039:0.007875:0.009039:0.004109
samples potentially represent an early time point in HGS development. Establishing and :@0.117647:0.918325:0.856956:0.918325:0.856956:0.897952:0.117647:0.897952:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.003835:0.011502:0.010820:0.006209:0.009039:0.011391:0.006437:0.005798:0.009405:0.005387:0.005182:0.009724:0.003835:0.007442:0.009131:0.011071:0.007442:0.009039:0.007875:0.009039:0.011391:0.006437:0.003835:0.009085:0.011756:0.003835:0.009291:0.009085:0.007601:0.005182:0.009724:0.003835:0.006437:0.005615:0.017485:0.009039:0.003835:0.011505:0.010843:0.005615:0.011391:0.006437:0.003835:0.005615:0.011756:0.003835:0.016412:0.015682:0.010112:0.003835:0.011322:0.009336:0.009633:0.008948:0.005182:0.010820:0.011071:0.017485:0.009039:0.011391:0.006437:0.004497:0.003835:0.012098:0.007510:0.006551:0.009108:0.010909:0.005250:0.005615:0.007556:0.011459:0.005615:0.011459:0.009861:0.003835:0.009085:0.011596:0.011391:0.004109